Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

...

10 Oct 2013

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

LUMO BodyTech, the makers of the LUMOback smart posture and movement feedback system, today announced national survey results revealing a widespread phenomenon LUMO calls 'Silicon Valley Syndrome'.

9 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

Virginia Tech faculty receives NIH New Innovator Award to research on influenza transmission

Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.

1 Oct 2013

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

The Vanderbilt Vaccine Research Program (VVRP) has received a contract from the National Institutes of Health (NIH) to continue its work as one of the nation's Vaccine and Treatment Evaluation Units (VTEU).

27 Sep 2013

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from Boston University's Slone Epidemiology Center and UC San Diego, in collaboration with the American Academy of Allergy Asthma and Immunology, have found 'reassuring' evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

EcoHealth Alliance to study land use alteration in disease emergence, climate change in Asia

EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the award of a three-year, $2 million award to address land use alteration as a significant driver of both disease emergence and climate change in Asia.

24 Sep 2013

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from the University of California, San Diego School of Medicine and Boston University, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

Scientists one step closer to developing universal flu vaccine

Scientists have moved closer to developing a universal flu vaccine after using the 2009 pandemic as a natural experiment to study why some people seem to resist severe illness.

23 Sep 2013

Research roundup: 'Cadillac' plan taxes; 'chronic care management' for substance abusers; long-term care services

As health coverage expands to tens of millions of Americans--through Medicaid expansion in states and the new state health insurance exchanges that will soon begin selling individual health coverage--some Americans with employer-sponsored health coverage are seeing their benefits decrease.

21 Sep 2013

Scientists aim at protecting adults from virulent strain of avian influenza virus

Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian (bird) influenza (flu) virus.

20 Sep 2013

Scientists are preparing for possible pandemic spread of new bird flu strain

Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.

20 Sep 2013

Gentiva, Harden enter into definitive merger agreement

Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, and Harden Healthcare Holdings, Inc., a leading provider of home health, hospice and community care services, announced today that they have entered into a definitive merger agreement whereby Gentiva will acquire Harden.

19 Sep 2013

Scientists prepare to test vaccines to protect against new bird flu strain

Scientists at Group Health Research Institute are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China earlier this year, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health to test vaccines to protect against the illness in adults.

19 Sep 2013

New blood test accurately differentiates viral and bacterial infections

A blood test developed by researchers at Duke Medicine showed more than 90-percent accuracy in distinguishing between viral and bacterial infections when tested in people with respiratory illnesses.

19 Sep 2013

Johns Hopkins establishes center to study ELSI of applying genomics to infectious disease treatment

The National Human Genome Research Institute has selected the Johns Hopkins Berman Institute of Bioethics to establish a "Center of Excellence" to study the ethical, legal and social implications of genomic research.

19 Sep 2013

Mitsubishi Tanabe Pharma acquires Medicago

Mitsubishi Tanabe Pharma Corporation and Medicago Inc. announced today the completion of the previously announced acquisition of Medicago Inc. by MTPC.

18 Sep 2013

Study: Rate of California ED visits higher among adult Medicaid beneficiaries

Emergency department (ED) use has been affected by insurance patterns over time and will likely be further affected by expansions of coverage from health care reform." Uninsured patients are often thought of as high and frequently inappropriate ED users, but insured patients, particularly those with Medicaid coverage, may have difficulties accessing primary care and may rely on EDs more frequently than uninsured patients, write Renee Y. Hsia, M.D., M.Sc., of the University of California, San Francisco, and colleagues.

18 Sep 2013

PCI announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging

Packaging Coordinators, Inc. (PCI), a global supplier of pharmaceutical commercial packaging solutions and clinical trials services today announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging. The company’s new service offering is outlined in a new white paper that is available to download via PCI anti-counterfeiting white paper and details its innovative identification solution, which uses a unique identification code on each pack, generated and applied by the packer.

From Packaging Coordinators Inc. (PCI) 17 Sep 2013

Pandemic News and Research

Further Reading

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

Virginia Tech faculty receives NIH New Innovator Award to research on influenza transmission

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

EcoHealth Alliance to study land use alteration in disease emergence, climate change in Asia

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Scientists one step closer to developing universal flu vaccine

Research roundup: 'Cadillac' plan taxes; 'chronic care management' for substance abusers; long-term care services

Scientists aim at protecting adults from virulent strain of avian influenza virus

Scientists are preparing for possible pandemic spread of new bird flu strain

Gentiva, Harden enter into definitive merger agreement

Scientists prepare to test vaccines to protect against new bird flu strain

New blood test accurately differentiates viral and bacterial infections

Johns Hopkins establishes center to study ELSI of applying genomics to infectious disease treatment

Mitsubishi Tanabe Pharma acquires Medicago

Study: Rate of California ED visits higher among adult Medicaid beneficiaries

PCI announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging

Best practices - optimize qPCR processes for pathogen detection eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News